Joseph Oliveto
CIK 1437782 · President and CEO · last filed 2026-04-20
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$566.7K
Companies
2
Total Filings
21
Lifetime Open-Market Net
-$545.6K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MIST | President and CEO | 446,244 | $1.27 | $566.7K | -$555.7K | 12 | 2026-04-20 |
| Chelsea Therapeutics International, Ltd. (CHTP) Delisted | President and CEO | 3,500 | — | — | $10.0K | 9 | 2014-01-24 |
Recent Filings · Page 3 of 3
21 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2008-06-17 | Chelsea Therapeutics International, Ltd. (CHTP) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 21–21 of 21
Prev
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.